Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 695501 Autoinjector Handling in RA
NCT02636907Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2016
- Primary completion
- Jun 2016
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Boehringer Ingelheim. Started Jan 2016; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02636907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636907.